Ellagic acid coordinately attenuates Wnt/[beta]-catenin and NF-[kappa]B signaling pathways to induce intrinsic apoptosis in an animal model of oral oncogenesis

Constitutive activation of the Wnt signaling pathway and its downstream effectors plays a key role in neoplastic transformation. The objective of this study was to investigate the effect of ellagic acid, a plant-derived polyphenol on Wnt/[beta]-catenin signaling and its downstream circuits- NF-[kappa]B and mitochondrial apoptosis in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis model. Hamsters were divided into six groups. The right buccal pouches of animals in groups 1-4 were painted with 0.5% DMBA three times a week for 14 weeks. Animals in groups 2-4 received in addition basal diet containing ellagic acid at a concentration of 0.1, 0.2, and 0.4% in the diet. Group 5 animals were given 0.4% ellagic acid alone. Group 6 animals served as control. The expression of the members of Wnt and NF-[kappa]B signaling and intrinsic apoptosis was evaluated by western blot analysis. Dietary supplementation of 0.4% ellagic acid suppressed the development of HBP carcinomas by preventing the constitutive activation of Wnt pathway through the downregulation of Fz, Dvl-2, GSK-3[beta] and nuclear translocation of [beta]-catenin. Abrogation of Wnt signaling by ellagic acid was also associated with inactivation of NF-[kappa]B and modulation of key components of the mitochondrial apoptotic network. Our findings suggest a functional crosstalk between Wnt and NF-[kappa]B signaling pathways in HBP carcinomas that is blocked by ellagic acid supplementation. Dietary ellagic acid that targets the Wnt/[beta]-catenin pathway as well as its downstream signaling mediators is a unique candidate for cancer chemoprevention.[PUBLICATION ABSTRACT]